|
1
|
Xu T, Tang J, Gu M, Liu L, Wei W and Yang
H: Recurrent nasopharyngeal carcinoma: a clinical dilemma and
challenge. Curr Oncol. 20:e406–e419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braccini AL, Haberer-Guillerm S, Azria D,
et al: Radioanatomy of rhinopharyngeal carcinoma. Cancer Radiother.
17:715–723. 2013.In French. View Article : Google Scholar
|
|
3
|
Wright CM, Dan T, Dicker AP and Simone NL:
microRNAs: The short link between cancer and RT-induced DNA damage
response. Front Oncol. 4:1332014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen HC, Chen GH, Chen YH, et al: MicroRNA
deregulation and pathway alterations in nasopharyngeal carcinoma.
Br J Cancer. 100:1002–1011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu CX, Xu M, Tan L, et al: MicroRNA
miR-214 regulates ovarian cancer cell stemness by targeting
p53/Nanog. J Biol Chem. 287:34970–34978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang M, Zhao C, Shi H, et al: Deregulated
microRNAs in gastric cancer tissue-derived mesenchymal stem cells:
novel biomarkers and a mechanism for gastric cancer. Br J Cancer.
110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Penna E, Orso F, Cimino D, et al: miR-214
coordinates melanoma progression by upregulating ALCAM through
TFAP2 and miR-148b downmodulation. Cancer Res. 73:4098–4111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derfoul A, Juan AH, Difilippantonio MJ,
Palanisamy N, Ried T and Sartorelli V: Decreased microRNA-214
levels in breast cancer cells coincides with increased cell
proliferation, invasion and accumulation of the Polycomb Ezh2
methyltransferase. Carcinogenesis. 32:1607–1614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Li J, Wang X, Zheng C and Ma W:
Downregulation of microRNA-214 and overexpression of FGFR-1
contribute to hepatocellular carcinoma metastasis. Biochem Biophys
Res Commun. 439:47–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang ZC, Li YY, Wang HY, et al: Knockdown
of miR-214 promotes apoptosis and inhibits cell proliferation in
nasopharyngeal carcinoma. PLoS One. 9:e861492014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brower JV, Clark PA, Lyon W and Kuo JS:
MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem
cells. Neurochem Int. 77:68–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang JT, Wang J, Srivastava V, Sen S and
Liu SM: MicroRNA machinery genes as novel biomarkers for cancer.
Front Oncol. 4:1132014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He ML, Luo MX, Lin MC and Kung HF:
MicroRNAs: potential diagnostic markers and therapeutic targets for
EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta.
1825:1–10. 2012.
|
|
16
|
Yu BL, Peng XH, Zhao FP, et al:
MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma
by repressing TOB2 expression. Int J Oncol. 44:1215–1222.
2014.PubMed/NCBI
|
|
17
|
Deng M, Ye Q, Qin Z, et al: miR-214
promotes tumorigenesis by targeting lactotransferrin in
nasopharyngeal carcinoma. Tumour Biol. 34:1793–1800. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Renault TT, Teijido O, Antonsson B, Dejean
LM and Manon S: Regulation of Bax mitochondrial localization by
Bcl-2 and Bcl-x(L): keep your friends close but your enemies
closer. Int J Biochem Cell Biol. 45:64–67. 2013. View Article : Google Scholar
|
|
19
|
Renault TT and Manon S: Bax: Addressed to
kill. Biochimie. 93:1379–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kumarswamy R and Chandna S: Putative
partners in Bax mediated cytochrome-c release: ANT, CypD, VDAC or
none of them? Mitochondrion. 9:1–8. 2009. View Article : Google Scholar
|
|
21
|
Wu X and Deng Y: Bax and BH3-domain-only
proteins in p53-mediated apoptosis. Front Biosci. 7:d151–d156.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cory S and Adams JM: Killing cancer cells
by flipping the Bcl-2/Bax switch. Cancer Cell. 8:5–6. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Li X, Zhang Y and Zhou K: Bax
inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal
carcinoma cells. Mol Cell Biochem. 333:1–7. 2010. View Article : Google Scholar
|
|
24
|
Li H, Xie M, Xu G and Li Y: Effect of
transduction bax gene on experimental nasopharyngeal carcinoma.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 36:430–432. 2001.In Chinese.
|
|
25
|
Yan H, Xu T, Zhao H, Lee KC, Wang HY and
Zhang Y: Isoflurane increases neuronal cell death vulnerability by
downregulating miR-214. PLoS One. 8:e552762013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L and Zhang Y: Halothane increases
neuronal cell death vulnerability by downregulating miR-214 and
upregulating Bax. Int J Clin Exp Med. 6:452–460. 2013.PubMed/NCBI
|
|
27
|
Adlakha YK and Saini N: MicroRNA-128
downregulates Bax and induces apoptosis in human embryonic kidney
cells. Cell Mol Life Sci. 68:1415–1428. 2011. View Article : Google Scholar
|
|
28
|
Li JH, Xiao X, Zhang YN, et al: MicroRNA
miR-886-5p inhibits apoptosis by down-regulating Bax expression in
human cervical carcinoma cells. Gynecol Oncol. 120:145–151. 2011.
View Article : Google Scholar
|
|
29
|
Ji S, Shao G, Lv X, et al: Downregulation
of miRNA-128 sensitises breast cancer cell to chemodrugs by
targeting Bax. Cell Biol Int. 37:653–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
